treatment of HER2- gastro- positive oesophageal junction cancer
J., Van Cutsem E., Feyereislova in (2010), A., combination with chemotherapy versus chemotherapy alone for treatment of HER2- gastro- positive oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial", Lancet, 376 (9742), 687-97.
J ., Van Cutsem E ., Feyereislova in ( 2010 ), A ., combination with chemotherapy versus chemotherapy alone for treatment of HER2- gastro- positive oesophageal junction cancer ( ToGA ) : A phase 3, open-label, randomised controlled trial", Lancet, 376 ( 9742 ), 687-97 .